Effect of Multiple Dosing With BI 201335 on the Safety, Pharmacokinetics and Pharmacodynamics of Steady-state Methadone and Buprenorphine/Naloxone in Subjects on Stable Addiction Management Therapy
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2014
At a glance
- Drugs Faldaprevir (Primary) ; Buprenorphine/naloxone; Methadone
- Indications Hepatitis C; Opioid abuse
- Focus Pharmacokinetics
- 01 Oct 2013 Results will be presented at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) according to a Boehringer Ingelheim media release.
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Oct 2012 Planned End Date changed from 1 Oct 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.